Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis

BACKGROUND: The aim of this study was to evaluate the efficacy and safety of osimertinib for the treatment of leptomeningeal metastases (LM) from epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). METHODS: We conducted a systematic review and meta-analysis to aggregat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Lei, Zhen, Junjie, Shan, Changguo, Lai, Mingyao, Hong, Weiping, Wang, Hui, Ye, Mingting, Yang, Yanying, Li, Shaoqun, Zhou, Zhaoming, Zhou, Jiangfen, Hu, Qingjun, Li, Juan, Tian, Xuwei, Chen, Longhua, Cai, Linbo, Xie, Zhanhong, Zhou, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403821/
https://www.ncbi.nlm.nih.gov/pubmed/37542339
http://dx.doi.org/10.1186/s40001-023-01219-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403821/
https://www.ncbi.nlm.nih.gov/pubmed/37542339
http://dx.doi.org/10.1186/s40001-023-01219-y

Ejemplares similares